Navigation Links
Health Robotics Announces Partnership in the People's Republic of China With The Devon International Group
Date:12/29/2008

BOZEN, Italy, December 29 /PRNewswire/ -- Health Robotics today announced that it has signed a definitive agreement with the Devon International Group (DIG), whereby DIG has acquired the exclusive rights to Health Robotics' CytoCare(TM) and i.v.STATION(TM) robots in the People's Republic of China. Health Robotics solutions offer unique benefits with great appeal to Government and Hospital officials in China, such as eliminating human handling of chemotherapy and other hazardous drugs during preparation, greatly improving accuracy, and reducing potentially fatal medication errors. DIG will initially staff its Health Robotics product team at its Beijing and Shanghai office locations, in addition to planned local manufacturing operations.

CytoCare(TM) is the world's first and only automated robotic system for the safe preparation of hazardous patient-specific IV medications. Originally developed for Cancer Therapy, CytoCare(TM) has also been proven to compound Monoclonal Antibodies Therapy IV Admixtures to treat patients with Crohn's disease, Organ Transplants, Multiple Sclerosis, Rheumatoid Arthritis, and Infectious Diseases. i.v.STATION(TM) is the world's first and only automated, point-of-care-distributed, and fail-safe robotic system for the sterile and accurate preparation of non-hazardous IV Admixtures.

"Given DIG's strong presence in the People's Republic of China with some of our other high-tech manufacturing subsidiaries, we embarked in due diligence with our local partners, Government officials, and leading healthcare providers to determine if this was the right time to bring Health Robotics' unique technology to China. Increased safety for patients and clinicians, higher accuracy of IV Admixtures, reduced waste, and improved efficiency of hospitals' pharmacy workflow are among the key benefits that I have witnessed in North America for both CytoCare(TM) and i.v.STATION(TM). After I personally me
'/>"/>

SOURCE Health Robotics SRL
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., SAN DIEGO, Nov. 9 BioM...y that the company has received commitments from l...nsecured line of credit by $65 million to an aggre... terms of the facility. The weighted-average effe...t was 1.35% as of September 30, 2009. The maturity...
(Date:11/9/2009)..., SAN DIEGO, Nov. 9 NexBio, Inc. a...annual American College of Allergy, Asthma, and Im...entitled "DAS181 (Fludase®), a Sialidase, Dec...mmatory Effects in Animal Models of Asthma". ,,...oad spectrum host-targeting drug candidate being s...
(Date:11/9/2009)... Product release is a researc...jects, research facilities and research safety stu... , Cedar Knolls, NJ (PRWE...unced today that it has unveiled Pristima™ V...research facilities that track the use and care of...
(Date:11/8/2009)..., MOUNTAIN VIEW, Calif. Nov. 5, 2009 Complete...ing company, today announced publication of a repo...tary DNA sequencing platform, including analysis o... The consumables cost for these three genomes sequ...rays ranged from $8,005 for 87x coverage to $1,726...
Breaking Biology Technology:BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2
... Biotech Products, L. P. Supports Program to Recog...o recognize the,extraordinary commitment of oncolo...ounced its support of CURE magazine,s 2008 Extraor...nors one of the thousands of,exceptional oncology ...cation, compassion and helpfulness. Last year, mor...
...ands the Company,s Clinical Stage Product Portfoli...uticals,Inc. today announced that it is has comple...and commercialize products under AstraZeneca,s IP ...tors (AI) in combination with,estrogen and progest...Meditrina,s clinical stage product portfolio which...
...ERSBURG, Md., Feb. 6 Iomai Corporation,(Nasdaq: ...ompany,s,president and chief executive officer, wi...onference in New York City on Tuesday, Feb. 12. Mr... Time in the in New Amsterdam,Suite of the Waldorf...ate and clinical milestones and,detail the results...
Other Biology Technology:Call for Entries - 2008 CURE Extraordinary Healer Award for Oncology Nursing 2Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca 2Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca 3Iomai CEO to Speak at BIO CEO & Investor Forum on Feb. 12 2
(Date:11/9/2009)...-- Genencor, a division of Danisco, has won the na...n Institute of Chemical Engineers (AIChE) for its ... ethanol. Yesterday, Robert Davis, Chair of the AI...n Steele, who is Marketing Director, Biomass Enzym...n Kelley, who is Senior Engineer, Biomass Applicat...
(Date:11/8/2009)...rdue University have discovered a new approach for...uries using nano-spheres that could be injected in...nthetic "copolymer micelles" are drug-delivery sph...00 times smaller than the diameter of a red blood ...liver drugs for cancer treatment and other therapi...
(Date:11/6/2009)...y with their arboreal hosts. But new research sugg...s of choice, the ants can get destructive to neigh...ovember issue of the American Naturalist , is the... and it reopens a centuries-old debate on the rela...tain species of plants and trees have cozy relatio...
Breaking Biology News(10 mins):Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Ants are friendly to some trees, but not others 2Biomimetic engineering design can replace spaghetti tangle of nanotubes in novel material 12400 1Biomimetic engineering design can replace spaghetti tangle of nanotubes in novel material 12400 2Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 1Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 2Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions 4509 3Streamwood Hospital Opens New Childrens Center to Meet Vital Community Need 47557 1Streamwood Hospital Opens New Childrens Center to Meet Vital Community Need 47557 2
...The legacy of nuclear weapons and nuclear energy d...ozens of sites across the United States and many m...e uranium is transported through ground water as u...um immobilization in contaminated ground water and...ic molecules known as electron donors to stimulate...
...in the UK and funded by the UK Biotechnology and B... a new drug discovery tool to identify a new playe...nding could spark a completely new class of drugs ...is week in Nature Chemical Biology researchers a...askatchewan graduate Dr Grant Churchill, explain h...
...ed an algorithm that meshes existing data to produ...respond to stimuli. Using this new method, Whitehe...logy scientists have analyzed alpha-synuclein toxi...t cell survival. Misfolded copies of the alpha-syn...rkinson,s disease. , RELEVANCE: Until now, data o...
Other Biology News:Patience pays off with methanol for uranium bioremediation 2Canadian scientist mines drugs database for new diabetes treatment 2Calculating gene and protein connections in a Parkinson's disease model 2Calculating gene and protein connections in a Parkinson's disease model 3Calculating gene and protein connections in a Parkinson's disease model 4
Mouse Anti-20S Proteasome alpha1, 2, 3, 5, 6, & 7-Subunits Monoclonal Antibody, Unconjugated, Clone MCP231 from Calbiochem
...een the 500 l and 4 ml centrifugal concentrators. ...spin products with low internal surface and membra...olutions. ,Available with a choice of PES, Cell...highest flexibility for process optimisation. ,A...
Mouse Anti-HSV-2 Glycoprotein G-2 Monoclonal Antibody, Unconjugated, Clone H1206 from Meridian Life Science, Inc.
...Region By immunoblotting the antibody reacts again...free MMP-2 or MMP-2 bound to TIMP-2. affinity isol... Solution in 0.01 M phosphate buffered saline, pH ...e. synthetic peptide corresponding to the hinge re...
Biology Products: